Matthew D. Neal: From Platelet Biology to Patient Impact at ISTH 2026
Matthew D. Neal, Associate Professor of Surgery, Critical Care Medicine, and Clinical and Translational Science at University of Pittsburgh School of Medicine, Director of Emergency General Surgery at UPMC, shared on LinkedIn:
”Proud to see Department of Surgery Pittsburgh Trauma and Transfusion Medicine Research Center (TTMRC) well represented at ISTH 2026 in Paris.
Our teams showcased innovative work across trauma, thrombosis, platelet biology, and translational science, while connecting with international colleagues advancing hemostasis and thrombosis research. It is inspiring to see the impact of our team on the global stage.
Grateful to be part of such a dedicated and collaborative community pushing the field forward.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis